Profile

Adrian Harel is the founder and currently serves as the Chief Executive Officer & Director of Medicortex Finland Oyj, a company founded in 2014.
Dr. Harel also held former positions as the Chief Executive Officer of Meditor Pharmaceuticals Ltd., Aminolab Technologies 2000 Ltd., ProNeuron Oy, Brainstorm Cell Therapeutics, Inc., Sepal Pharma Ltd., and WBT Ltd.
Dr. Harel's education includes a doctorate from the Weizmann Institute of Science, an MBA from the University of Haifa, and another doctorate from Washington University School of Medicine.

Adrian Harel active positions

Former positions of Adrian Harel

CompaniesPositionEnd
BRAINSTORM CELL THERAPEUTICS INC. Chief Executive Officer 2013-12-23
Meditor Pharmaceuticals Ltd. President -
Aminolab Technologies 2000 Ltd. President -
Sepal Pharma Ltd. Chief Operating Officer 2006-12-31
WBT Ltd. Chief Operating Officer 2006-12-31
See the detail of Adrian Harel's experience

Training of Adrian Harel

Weizmann Institute of Science Doctorate Degree
University of Haifa Masters Business Admin
Washington University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adrian Harel's experience

Connections

13

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BRAINSTORM CELL THERAPEUTICS INC.

Health Technology

MEDICORTEX FINLAND OYJ

Health Technology

Private companies5
Sepal Pharma Ltd.

Meditor Pharmaceuticals Ltd.

WBT Ltd.

Aminolab Technologies 2000 Ltd.

ProNeuron Oy

See company connections